OncoLink Cancer Treatment and Resources
Link to OncoLink

Prognostic Value of p53 for Local Failure in Mastectomy-Treated Breast Cancer Patients

R. C. Zellars, S. G. Hilsenbeck, G. M. Clark, et al.
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001

Reviewers: Li Liu, MD
Source: Journal of Clinical Oncology, Vol. 18, No 9, 1906-1913, (May) 2000

Introduction

Randomized clinical trials have established that radiation therapy improves the local regional control and survival in selected breast cancer patients treated with mastectomy. However, only about 50% of patients will benefit from post-mastectomy irradiation and the remaining 50% still die with uncontrolled local-regional disease. Much effort has been made to identify breast cancer patients at greatest risk of local-regional failure and most likely to benefit from postmastectomy irradiation. Dr. Zellars and his colleagues examined the tumor suppressor gene p53 as a predictor of local-regional failure.

Materials and Methods

p53 levels were examined retrospectively in 1,530 breast cancer patients treated with mastectomy. In 259 patients, mastectomy was followed with adjuvant radiation therapy.

Results

After a median follow-up of 62 months, the researchers found:

  • Patients with p53-positive tumors had a significantly higher recurrence rate, whether they received adjuvant radiation or not.
  • In patients not treated with radiation, the local failure rate was 9.1% with p53-negative tumors and 16.5% for p53-positive tumors.
  • In patients treated with radiation, the local failure rate was 9.3% with p53-negative tumors and 21.5% in p53-positive tumors.

Discussion

In this study, p53-positive breast cancers were strongly associated with an increased risk of local recurrence after mastectomy, regardless of adjuvant radiation treatment. This finding may help physicians to identify a subgroup of breast cancer patients who are at greater risk of local-regional failure and who therefore may benefit from more aggressive local management.

OncoLink I wish u knew...

Dr. Vapiwala discusses the Affordable Care Act and access to healthcare. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS